Fundraising Fox

Matthew R. Patterson

Investor

Venture Partner at SR One Capital Management · Chairman of the Board of Directors at Rezo Therapeutics

San Francisco Bay Area

About

Matthew R. Patterson is a Venture Partner at SR One Capital Management with over 30 years in the research, development, and commercialization of therapeutics. He co-founded Audentes Therapeutics in 2012 and served as its CEO until its 2020 acquisition by Astellas Pharma, and previously worked at Genzyme, BioMarin Pharmaceutical, Amicus Therapeutics, and Iris Medicine, as well as serving as an Entrepreneur-In-Residence at OrbiMed. He holds a Bachelor's degree in Biochemistry from Bowdoin College.

Contact· self-published, not guessed

Likely email· guessed from name + firm domain, not firm-published

Invests in

Biotech

Chairman of the Board of Directors at Rezo Therapeutics

Intro paths

→

In turn, Matthew can intro founders to Rezo Therapeutics's investors below.

Rezo Therapeutics's investors · 6

Andreessen HorowitzMenlo Park · $500K – $50M checks · since 2022ARCH Venture PartnersChicago · $50K – $250M checks · since 2025HAWKTAILSan FranciscoNorwest Venture PartnersMenlo Park · $10M – $30M checks · since 2022SR One Capital ManagementRedwood CityValkyrie Ventures Management, LlcPark City

Co-founders at Rezo Therapeutics

NK
Nevan KroganCo-Founder
SB
Sourav BandyopadhyayCo-Founder
NB
Norbert BischofbergerCo-Founder
NJ
Natalia JuraCo-Founder
GSGeorge Scangos
George ScangosCo-Founder
KS
Kevan ShokatCo-Founder

Investments

Board seats

Addition TherapeuticsAddition TherapeuticsRemix Therapeutics, Inc.Vor Biopharma, Inc.

Sources: the firm's website · SEC Form D filings.

Colleagues at SR One Capital Management

Alicia Hasson
Executive Assistant at SR One Capital Management
Amit Mehta
Venture Partner - US Investments at SR One Capital Management
Amit Shah
Principal at SR One Capital Management
Ann Ng
Finance Director at SR One Capital Management
Brian Gallagher
Partner at SR One Capital Management
Briana Wilson
Senior Administrative Assistant at SR One Capital Management
Catalina Kazi
Legal & Compliance Counsel at SR One Capital Management
Chris Chai
Operating Partner - Portfolio Capital Raising at SR One Capital Management

Frequently asked questions

Who is Matthew R. Patterson?
Matthew R. Patterson is a Venture Partner at SR One Capital Management with over 30 years in the research, development, and commercialization of therapeutics. He co-founded Audentes Therapeutics in 2012 and served as its CEO until its 2020 acquisition by Astellas Pharma, and previously worked at Genzyme, BioMarin Pharmaceutical, Amicus Therapeutics, and Iris Medicine, as well as serving as an Entrepreneur-In-Residence at OrbiMed. He holds a Bachelor's degree in Biochemistry from Bowdoin College.
Where does Matthew R. Patterson work?
Matthew R. Patterson is Venture Partner at SR One Capital Management and Chairman of the Board of Directors at Rezo Therapeutics.
What does Matthew R. Patterson invest in?
Matthew R. Patterson invests in Biotech.
What boards does Matthew R. Patterson sit on?
Matthew R. Patterson holds tracked board seats at Addition Therapeutics, Addition Therapeutics, Remix Therapeutics, Inc., Vor Biopharma, Inc..